rs117931394

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.2980G>A​(p.Ala994Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00551 in 1,606,384 control chromosomes in the GnomAD database, including 443 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A994A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0064 ( 55 hom., cov: 34)
Exomes 𝑓: 0.0054 ( 388 hom. )

Consequence

COL6A2
NM_001849.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.967

Publications

8 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001766324).
BP6
Variant 21-46132472-G-A is Benign according to our data. Variant chr21-46132472-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.2980G>A p.Ala994Thr missense_variant Exon 28 of 28 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.2980G>A p.Ala994Thr missense_variant Exon 28 of 28 1 NM_001849.4 ENSP00000300527.4 P12110-1

Frequencies

GnomAD3 genomes
AF:
0.00646
AC:
984
AN:
152232
Hom.:
55
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.00889
Gnomad FIN
AF:
0.0119
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00131
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.0119
AC:
2860
AN:
240140
AF XY:
0.0108
show subpopulations
Gnomad AFR exome
AF:
0.000636
Gnomad AMR exome
AF:
0.000349
Gnomad ASJ exome
AF:
0.00254
Gnomad EAS exome
AF:
0.123
Gnomad FIN exome
AF:
0.0126
Gnomad NFE exome
AF:
0.00152
Gnomad OTH exome
AF:
0.00654
GnomAD4 exome
AF:
0.00541
AC:
7868
AN:
1454032
Hom.:
388
Cov.:
34
AF XY:
0.00542
AC XY:
3920
AN XY:
723006
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33412
American (AMR)
AF:
0.000337
AC:
15
AN:
44572
Ashkenazi Jewish (ASJ)
AF:
0.00307
AC:
80
AN:
26056
East Asian (EAS)
AF:
0.128
AC:
5069
AN:
39572
South Asian (SAS)
AF:
0.00518
AC:
446
AN:
86122
European-Finnish (FIN)
AF:
0.0114
AC:
558
AN:
48820
Middle Eastern (MID)
AF:
0.00261
AC:
15
AN:
5758
European-Non Finnish (NFE)
AF:
0.00112
AC:
1241
AN:
1109562
Other (OTH)
AF:
0.00728
AC:
438
AN:
60158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
477
954
1432
1909
2386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00645
AC:
982
AN:
152352
Hom.:
55
Cov.:
34
AF XY:
0.00796
AC XY:
593
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000625
AC:
26
AN:
41582
American (AMR)
AF:
0.000849
AC:
13
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.128
AC:
663
AN:
5178
South Asian (SAS)
AF:
0.00890
AC:
43
AN:
4832
European-Finnish (FIN)
AF:
0.0119
AC:
127
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00131
AC:
89
AN:
68028
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
44
89
133
178
222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00776
Hom.:
91
Bravo
AF:
0.00704
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.0116
AC:
1408
Asia WGS
AF:
0.0420
AC:
145
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.000830

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 10, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 31, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 09, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Myosclerosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glutamate formiminotransferase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bethlem myopathy 1A Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ullrich congenital muscular dystrophy 1A;C1850671:Myosclerosis;CN029274:Bethlem myopathy 1A Benign:1
Feb 25, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
17
DANN
Benign
0.91
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.77
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-1.2
T
MutationAssessor
Benign
0.77
N
PhyloP100
0.97
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.35
N
REVEL
Benign
0.16
Sift
Benign
0.51
T
Sift4G
Benign
0.22
T
Polyphen
0.55
P
Vest4
0.062
MPC
0.14
ClinPred
0.0053
T
GERP RS
2.4
Varity_R
0.016
gMVP
0.62
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117931394; hg19: chr21-47552386; COSMIC: COSV52424277; COSMIC: COSV52424277; API